0.10
-9.52%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Rapid Dose Therapeutics
Its shares trade on Canadian Securities Exchange under the ticker DOSE.CN. It has been listed since 17 December 2018. In the fiscal year to 28 February 2026, it reported revenue of C$2.8m and a net loss of C$3.4m. At that date it held total assets of C$3.3m and shareholders' equity of −C$7.2m.
Rapid Dose Therapeutics Corp. engages in the provision of proprietary drug delivery technologies. The company is headquartered in Burlington, Ontario. The company went IPO on 2018-12-17. The firm provides disruptive drug delivery technologies designed to improve patient outcomes. The Company’s flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. The company offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product. The firm also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 17 Dec 2018
Leadership
Pay as last reported
- Mr. Mark UpsdellPresident, Chief Executive Officer, Director, since 2017C$150,000
- Mr. Doug HylandInterim Chief Financial OfficerC$157,750
- Mr. Jason LewisSenior Vice President - Business Development, since 2017C$150,000
- Mr. John MckimmDirectorC$17,485
- Ms. Marisa CornacchiaIndependent DirectorC$17,485
- Mr. Peter HaslerIndependent DirectorC$47,413
- Ms. Christine HrudkaIndependent DirectorC$17,485
- Ms. Angela O'LearyIndependent DirectorC$17,485
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Rapid Dose Therapeutics Corp. is headquartered in Burlington, Ontario, providing a central operational base.
- The company's flagship product, QuickStrip, is a thin, orally dissolvable film that delivers active ingredients quickly into the bloodstream.
- The firm provides production and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries.
Weaknesses
- The company operates with a single listed ticker, DOSE.CN, on the Canadian market.
- Rapid Dose Therapeutics Corp. went public in December 2018, indicating a relatively recent listing history.
- The business relies on a single primary product line centered around the QuickStrip technology platform.
Opportunities
- The QuickStrip Energy product delivers energizing caffeine, targeting the consumer wellness market.
- QuickStrip B12 delivers vitamin B12 to assist with metabolism and physical energy for health-conscious consumers.
- QuickStrip Sleep delivers melatonin to induce natural and healthy sleep, expanding into the sleep aid segment.
Threats
- QuickStrip Lidocaine is a dental product, exposing the firm to specific regulatory scrutiny in the dental sector.
- The company offers over-the-counter solutions, which face intense competition from established consumer health brands.
- Rapid Dose Therapeutics Corp. provides pharmaceutical drug delivery solutions, requiring strict adherence to complex healthcare regulations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.